{"schema_version":"1","generated_at":"2026-11-08T23:44:56.508Z","data_as_of":null,"url":"https://www.findmykol.com/kol/frederick-aronson","json_url":"https://www.findmykol.com/kol/frederick-aronson/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"frederick-aronson","name":"Frederick Aronson","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"New England Cancer Specialists","institution_url":"https://www.findmykol.com/institution/new-england-cancer-specialists","city":"Scarborough","state":"ME","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1417928334","openalex":"A5113790220"},"summary":"Frederick Aronson is an Oncology physician affiliated with New England Cancer Specialists. OpenAlex indexes 44 publications with 1,700 citations (h-index 22).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":44,"cited_by_count":1700,"h_index":22,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"ABBVIE INC.","program_year":2025,"amount_usd":34.46,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417928334"},{"payer":"Pharmacyclics LLC, An AbbVie Company","program_year":2023,"amount_usd":29.5,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1417928334"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1417928334","source":"payments"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"Ibrutinib increased survival more than chlorambucil in older patients with untreated chronic lymphocytic leukemia","year":2016,"journal":"Annals of Internal Medicine","source_url":"https://doi.org/10.7326/acpjc-2016-164-8-044","status":"verified"},{"title":"Use of Biological Response Modifiers for Management of Renal Cell Carcinoma","year":2010,"journal":"Urologia Internationalis","source_url":"https://doi.org/10.1159/000282156","status":"verified"},{"title":"Introduction","year":2010,"journal":"Urologia Internationalis","source_url":"https://doi.org/10.1159/000282145","status":"verified"},{"title":"The Secondary Response of Chickens Given a Primary Inoculation of Bovine Serum Albumin at Different Ages","year":2009,"journal":"International Archives of Allergy and Applied Immunology","source_url":"https://doi.org/10.1159/000229115","status":"verified"},{"title":"Toxicity of Immunotherapy with Interleukin-2 and Lymphokine-Activated Killer Cells","year":2008,"journal":"Pathology and Immunopathology Research","source_url":"https://doi.org/10.1159/000157075","status":"verified"}],"source":"works"},"contact":{"address_1":"100 CAMPUS DRIVE","address_2":"SUITE 108","city":"Scarborough","state":"ME","zip":"04074","phone":"207-396-7600","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1417928334","source":"identity"},"similar":[{"name":"Chiara Battelli","slug":"chiara-battelli","institution":"New England Cancer Specialists","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/chiara-battelli","json_url":"https://www.findmykol.com/kol/chiara-battelli/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":39}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-10-03","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}